upper
respiratori
infect
commonplac
especi
young
peopl
often
contagi
respiratori
tract
consist
upper
respiratori
tract
urtnos
paranas
sinus
pharynx
larynx
discuss
ch
lower
respiratori
tract
lrt
respiratori
airway
trachea
bronchi
bronchiol
lung
respiratori
bronchiol
alveolar
duct
alveolar
sac
alveoli
discuss
chapter
protect
mechan
respiratori
tract
includ
mucociliari
line
particl
pathogen
trap
mucu
driven
ciliari
action
ciliari
elev
pharynx
mucociliari
tran
port
declin
age
effect
clinic
infect
prove
lymphoid
tissu
waldey
ring
adenoid
palatin
lingual
tonsil
import
develop
immun
respons
pathogen
howev
best
respiratori
defenc
mechan
cough
reflex
compon
includ
cough
receptor
affer
ent
nerv
cough
centr
effer
nerv
effector
muscl
impair
may
seen
older
patient
condit
associ
lower
conscious
eg
sed
use
neurolog
diseas
weaken
protect
dysphagia
impair
oesophag
motil
may
exacerb
tendenc
aspi
rate
foreign
materi
alveolar
defenc
mechan
includ
mac
rophag
immunocyt
surfact
phospholipid
immunoglobulin
g
igg
ige
secretori
iga
complement
compon
factor
b
mani
immun
defect
manifest
recurr
respiratori
infect
lung
function
vital
ga
exchang
blood
absorb
oxygen
releas
carbon
dioxid
normal
ga
exchang
requir
adequ
alveolar
ventil
normal
ventilationblood
flow
relationship
adequ
alveolarcapillari
membran
surfac
area
breath
ven
tilat
depend
respiratori
drive
react
respiratori
load
process
requir
work
result
ga
exchang
oxygen
transport
combin
haemoglobin
erythro
cyte
small
amount
dissolv
plasma
oxyhaemoglobin
dissoci
curv
sigmoid
oxygen
satur
fall
amount
transport
tissu
brain
fall
rapidli
high
temperatur
acidosi
rais
co
rais
diphosphoglycer
level
encourag
oxygen
offload
wherea
fetal
haemoglobin
carboxyhaemoglobin
con
trari
effect
chronic
hypoxaemia
eg
high
altitud
stimul
releas
erythropoietin
kidney
rise
red
cell
pro
duction
rais
athlet
abus
erythropoietin
gain
competit
advantag
ch
common
lrt
disord
asthma
chronic
obstruct
pulmonari
diseas
copd
respiratori
disord
common
often
caus
aggrav
tobacco
smoke
may
significantli
affect
gener
anaesthesia
ga
consciou
sedat
cs
sinc
often
contraindica
tion
use
benzodiazepin
opioid
ga
agent
respira
tori
depress
impair
ga
exchang
lead
labour
breath
caus
signific
incapac
featur
includ
cough
sputum
product
wheez
dyspnoea
chest
pain
cyanosi
fingerclub
fig
use
accessori
muscl
respir
indraw
intercost
space
hyperinfl
abnorm
chest
shape
movement
respiratori
rate
breath
sound
cough
may
featur
respiratori
problem
chronic
may
herald
seriou
diseas
exampl
copd
cancer
infec
tion
tuberculosi
mucoid
mucopurul
sputum
often
featur
fig
purul
sputum
indic
acut
bronchiti
bronchiectasi
lung
abscess
blood
haemoptysi
bloodstain
sputum
though
common
acut
infect
especi
preexist
copd
bronchiectasi
pulmonari
embol
may
herald
even
seriou
condit
exampl
possibl
one
due
carcinoma
tuberculosi
wheez
caus
airway
obstruct
typic
sign
asthma
copd
breathless
dyspnoea
distress
ing
may
caus
respiratori
cardiovascular
diseas
anaemia
particularli
omin
persist
rest
excess
resist
load
asthma
copd
cystic
fibro
si
impair
airflow
elast
load
increas
exampl
interstiti
fibrosi
muscl
paralysi
obes
diagnosi
respiratori
disord
clinic
featur
sup
port
imag
especi
chest
radiographi
spiral
comput
tomographi
ct
scan
lung
quick
breathhold
therefor
instead
produc
stack
individu
ct
slice
may
misalign
due
patient
movement
breath
slice
provid
highresolut
three
dimension
imag
respiratori
function
test
measur
individu
compon
respiratori
process
spirometri
basic
screen
test
assess
ing
mechan
load
problem
quantif
involv
determi
nation
vital
capac
vc
slow
vital
capac
svc
andor
forc
vital
capac
fvc
speed
maxim
expiratori
flow
mef
fig
health
normals
vc
expel
second
fev
peak
flow
meter
measur
peak
expiratori
flow
rate
pefr
earliest
portion
forc
expir
simpl
measur
airflow
obstruct
fev
much
smaller
fraction
vc
lung
restrict
diminish
vc
mostli
expel
second
serial
mea
urement
eg
asthma
provid
valuabl
inform
diseas
progress
revers
airway
obstruct
usual
assess
spirometri
use
bronchodil
agent
arteri
blood
ga
analysi
yield
consider
inform
ga
exchang
effici
arteri
hypoxaemia
adult
defin
pao
kpa
breath
room
air
although
usual
treat
clinic
import
unless
kpa
oxygen
satur
less
tabl
arteri
carbon
dioxid
tension
paco
use
invers
pro
portion
index
effect
alveolar
ventil
henc
high
paco
taken
indic
poor
alveolar
ventil
alveolar
hypoventila
tion
rais
paco
normal
ph
probabl
repres
primari
ventilatori
chang
present
long
enough
renal
mechan
compens
chronic
ventilatori
failur
ventilationblood
flow
relationship
simpli
assess
consid
size
differ
amount
oxygen
carbon
dioxid
blood
air
differ
small
lung
work
ing
effici
dispar
ventilationblood
flow
ratio
result
abnorm
wide
differ
alveolararteri
po
arterialalveolar
pco
gradient
abnorm
alveolar
capillari
surfac
area
assess
measur
uptak
carbon
monoxid
usual
abnorm
diffus
interstiti
inflam
matori
fibrot
process
emphysema
assess
bronchial
reactiv
exercis
respons
help
evalu
breathless
simpl
exercis
test
provid
inform
overal
fit
appropri
cardiorespiratori
respons
radionuclid
lung
scan
blood
ga
analysi
sputum
cytolog
cultur
sometim
need
addit
manag
includ
oxygen
administr
mask
nasal
cannula
fig
lrt
disord
caus
signific
incapac
often
con
traindic
ga
even
cs
asthma
common
affect
overal
popul
increas
particularli
childhood
frequenc
highincom
countri
asthma
usual
begin
childhood
earli
adult
life
half
patient
asthma
develop
age
year
bronchial
hyperreact
caus
revers
airway
obstruct
smooth
muscl
constrict
bronchospasm
mucos
oedema
mucu
hypersecret
two
main
type
extrins
allerg
intrins
asthma
tabl
extrins
allerg
asthma
main
childhood
type
may
pre
cipit
allergen
anim
dander
feather
hair
drug
eg
nonsteroid
antiinflammatori
drug
nsaid
antibiot
ic
food
eg
egg
fish
fruit
milk
nut
hous
dust
mite
allergen
mould
patient
frequent
develop
allerg
diseas
eczema
hay
fever
drug
sensit
extrins
asthma
associ
ige
overproduct
allergen
exposur
releas
mast
cell
mediat
histamin
leukotrien
prostaglandin
bradykinin
platelet
activ
factor
caus
bronchospasm
oedema
asthmat
children
lose
asthma
improv
adulthood
intrins
asthma
usual
adult
onset
aller
gic
appear
rather
relat
mast
cell
instabl
airway
hyperrespons
trigger
includ
emot
stress
gastro
oesophag
reflux
vagal
mediat
respons
either
type
asthma
trigger
infect
especi
viral
mycoplasm
fungal
irrit
fume
eg
traffic
cigarett
smoke
exercis
possibl
due
cold
air
weather
chang
emot
stress
food
eg
nut
shellfish
strawberri
milk
addit
tartrazin
drug
eg
aspirin
nsaid
beta
blocker
angiotensinconvert
enzym
inhibitor
acei
wellcontrol
patient
asthma
clinic
featur
may
absent
asthmat
episod
symptom
may
includ
dysp
noea
cough
paroxysm
expiratori
wheezi
labour
expir
frequenc
sever
attack
vari
wide
individu
tabl
patient
may
becom
distress
anxiou
tachycard
reduc
chest
expans
use
accessori
respiratori
muscl
increas
ventilatori
effort
nasal
polyp
common
especi
aspirinsensit
asthmat
children
asthma
initi
suffer
repeat
cold
cough
malais
fever
often
night
asthma
typic
diagnos
patient
one
follow
wheez
cough
difficulti
breath
chest
tight
particularli
frequent
recurr
wors
night
earli
morn
occur
respons
wors
exercis
trigger
exposur
pet
cold
damp
air
emot
laughter
occur
without
associ
cold
often
person
histori
atop
disord
famili
histori
atop
disord
andor
asthma
widespread
wheez
heard
chest
auscult
histori
improv
symptom
lung
function
respons
adequ
therapi
prolong
asthmat
attack
refractori
treatment
may
lead
lifethreaten
statu
asthmaticu
persist
hour
failur
patient
complet
sentenc
indraw
intercost
muscl
rapid
puls
silent
chest
sign
exhaust
suggest
impend
respiratori
arrest
diagnosi
asthma
clinic
histori
present
base
recogn
characterist
pattern
episod
symptom
absenc
altern
explan
investig
includ
chest
radiograph
exclud
diagnos
pneumo
thorax
spirometri
serial
pefr
skin
test
blood
examin
usual
eosinophilia
rais
total
ige
specif
ige
antibodi
concentr
may
help
identifi
allergen
occasion
histamin
methacholin
challeng
use
diagnosi
unclear
children
intermedi
probabl
asthma
perform
spirometri
evid
airway
obstruct
assess
chang
fev
pefr
respons
inhal
bronchodil
revers
andor
respons
trial
treatment
speci
fie
period
signific
revers
treatment
trial
benefici
diagnosi
asthma
probabl
manag
includ
patient
educ
smoke
cessat
advic
avoid
identifi
irrit
allergen
use
drug
home
use
peak
flow
meter
allow
patient
monitor
progress
detect
deterior
may
requir
urgent
modif
treatment
treatment
base
amount
peak
flow
reduc
pefr
diari
kept
drug
use
asthma
manag
tabl
includ
oxygen
shortact
agonist
saba
salbutamol
corticosteroid
leukotrien
receptor
antagonist
omalizumab
recombin
human
monoclon
antiig
antibodi
reduc
antigen
specif
ige
inhal
longact
agonist
laba
may
need
fig
death
asthma
usual
result
failur
recogn
dete
riorat
reluct
use
corticosteroid
factor
studi
includ
air
pollut
associ
air
pollut
aggrav
exist
asthma
allergen
avoid
consist
evid
benefit
breastfeed
evid
protect
effect
relat
earli
asthma
electrolyt
consist
evid
benefit
fish
oil
fatti
acid
consist
evid
benefit
hous
dust
mite
measur
reduc
number
hous
dust
mite
affect
asthma
sever
immunotherapi
allergenspecif
immunotherapi
benefici
allerg
asthma
microbi
exposur
insuffici
evid
indic
use
probiot
pregnanc
reduc
incid
childhood
asthma
modifi
milk
formula
consist
evid
benefit
pet
control
trial
benefit
remov
pet
home
tobacco
exposur
cigarett
smoke
advers
affect
qualiti
life
lung
function
need
rescu
medic
longterm
control
inhal
steroid
associ
matern
smoke
increas
risk
infant
wheez
weight
reduct
associ
increas
bodi
mass
index
symptom
asthma
elect
dental
care
defer
sever
asthmat
better
phase
advis
patient
gener
practition
asthmat
patient
ask
bring
usual
medica
tion
come
dental
treatment
local
anaesth
sia
la
best
use
occasion
patient
may
react
sulphit
present
preserv
vasoconstrictorcontain
la
may
better
possibl
avoid
solut
contain
vasoconstr
tor
adrenalin
epinephrin
may
theoret
enhanc
risk
arrhythmia
betaagonist
contraind
patient
use
theophyllin
may
precipit
arrhythmia
rel
analgesia
nitrou
oxid
oxygen
prefer
intraven
sedat
give
immedi
control
sed
gener
better
avoid
acut
asthmat
attack
even
ben
zodiazepin
precipit
respiratori
failur
ga
best
avoid
may
complic
hypoxia
hyper
capnia
caus
pulmonari
oedema
even
cardiac
function
normal
cardiac
failur
cardiac
diseas
risk
post
oper
lung
collaps
pneumothorax
also
increas
halothan
better
enfluran
isofluran
desfluran
sevofluran
prefer
anaesthet
ketamin
may
use
children
allergi
penicillin
may
frequent
asthmat
drug
avoid
sinc
may
precipit
asthmat
attack
see
later
includ
list
box
acut
asthmat
attack
may
also
occasion
precipit
anxieti
import
attempt
lessen
fear
dental
treatment
gentl
handl
reassur
even
routin
dental
treatment
trigger
clinic
signific
declin
lung
function
approxim
asthmat
acut
asthmat
attack
usual
selflimit
respond
patient
usual
medic
betaagonist
inhal
statu
asthmaticu
potenti
fatal
emerg
ch
may
complic
caus
antiasthmat
drug
tabl
gastrooesophag
reflux
uncommon
occasion
tooth
eros
periodont
inflamm
greater
asthmat
without
respiratori
diseas
person
use
steroid
inhal
may
develop
oropharyng
candidosi
occasion
angina
bullosa
haemorrhagica
guidelin
manag
asthma
may
found
http
http
wwwniceorgukguidancequalitystandardsindevelopmentasthma
jsp
http
access
septemb
churgstrauss
syndrom
css
rare
potenti
fatal
system
vascul
similar
polyarter
nodosa
pan
character
sever
asthmalik
attack
peripher
eosinophilia
intrava
cular
extravascular
granuloma
format
eosinophil
infiltra
tion
skin
lesion
cardiopulmonari
involv
main
caus
death
css
diagnos
least
criteria
list
box
posit
surviv
untreat
css
combin
treatment
cyclophosphamid
prednisolon
prednison
provid
surviv
manag
problem
relat
patient
css
may
includ
re
piratori
impair
corticosteroid
treatment
ch
chronic
obstruct
pulmonari
diseas
copd
chronic
obstruct
airway
diseas
coad
common
chronic
slowli
progress
irr
versibl
diseas
frequent
combin
chronic
bronchiti
emphysema
character
breathless
wheez
airway
obstruct
cough
sputum
chronic
bronchiti
defin
excess
product
mucu
persist
cough
sputum
product
daili
month
year
consecut
year
lead
product
excess
viscou
mucu
ineffect
clear
airway
obstruct
stag
nate
becom
infect
usual
streptococcu
pneumonia
moraxella
catarrhali
haemophilu
influenza
patchi
area
alveolar
collaps
result
emphysema
dilat
air
space
di
tal
termin
bronchiol
destruct
alveoli
reduc
alveolar
surfac
area
avail
respiratori
exchang
copd
prefer
term
condit
airflow
obstruct
combin
airway
parenchym
damag
patient
previ
ousli
diagnos
chronic
bronchiti
emphysema
copd
character
airflow
obstruct
defin
fev
fvc
ratio
reduc
less
fev
diagno
si
copd
made
respiratori
symptom
eg
dyspnoea
cough
airflow
obstruct
fulli
rever
ibl
chang
significantli
month
usual
progr
sive
long
term
import
caus
copd
includ
cigarett
smoke
environment
pollut
dust
chemic
occup
exposur
variou
substanc
exposur
smoke
home
cook
heat
fuel
may
contribut
defici
antiproteolyt
enzym
rare
caus
emphysema
often
signific
airflow
obstruct
person
awar
copd
typic
remain
undiagnos
patient
fifti
differenti
asthma
import
tabl
diagnosi
copd
consid
patient
age
risk
factor
eg
smoke
exert
breath
less
chronic
cough
regular
sputum
product
frequent
winter
bronchiti
wheez
clinic
judgment
base
histori
physic
examin
confirm
airflow
obstruct
use
spirometri
postbronchodil
spirometri
assess
sever
dyspnoea
tabl
copd
character
breathless
wheez
airway
obstruct
cough
earli
morn
mucoid
sputum
product
investig
symptom
seem
disproportion
spirometr
impair
progress
dyspnoea
low
oxygen
satur
carbon
dioxid
accumu
lation
hypercapnia
metabol
acidosi
mean
patient
may
ultim
becom
dyspnoeic
rest
respiratori
crippl
especi
recumb
orthopnoea
eventu
develop
respiratori
failur
pulmonari
hypertens
right
ventricular
hypertrophi
rightsid
heart
failur
cor
pulmonal
two
clinic
pattern
copd
recogn
pink
puffer
patient
emphysema
manag
maintain
normal
blood
gase
hyperventil
alway
breathless
cyanos
rather
pink
vasodilat
blue
bloater
patient
chronic
bronchiti
lose
co
drive
fail
maintain
adequ
ventil
becom
hypercapn
hypox
central
cyanosi
cor
pulmonal
oedema
patient
respiratori
drive
low
po
thu
oxygen
administr
contraind
tabl
diagnosi
copd
base
upon
clinic
histori
presen
tation
investig
includ
chest
radiograph
may
show
hyperinfl
lung
field
loss
vascular
mark
arteri
blood
gase
measur
puls
oximetri
show
oxygen
satu
ration
less
spirometri
lung
function
test
reduc
case
fev
less
signifi
sever
copd
flowvolum
curv
show
typic
pattern
reduc
flow
rate
mid
lowerlung
volum
ratio
fev
fvc
less
confirm
airway
obstruct
patient
copd
famili
educ
diseas
requir
lifestyl
chang
medic
nondrug
therapi
includ
stop
smoke
nicotin
replac
therapi
bupropion
may
help
exercis
pulmonari
rehabilitationof
proven
benefit
weight
loss
improv
exercis
toler
vaccin
pneumococc
influenza
vaccin
drug
therapi
includ
shortact
bronchodil
anticholinerg
drug
ipra
tropium
bromid
agonist
salbutamol
treat
revers
compon
airway
diseas
corticosteroid
inhal
system
antibiot
amoxicillin
trimethoprim
tetracyclin
mucolyt
carbocistein
reduc
acut
exacerb
almost
onethird
longterm
oxygen
therapi
ltot
reduc
mortal
peopl
stabl
copd
remain
breathless
exacerba
tion
despit
use
shortact
bronchodil
offer
follow
mainten
therapi
fev
predict
use
either
longact
agonist
laba
longact
muscarin
antagonist
lama
fev
less
predict
either
laba
inhal
corticosteroid
ic
combin
inhal
lama
offer
lama
addit
laba
plu
ic
peopl
copd
remain
breathless
exacerb
despit
take
laba
plu
ic
irrespect
fev
provid
pulmonari
rehabilit
need
noninvas
ventil
niv
treatment
choic
persist
hyper
capnic
ventilatori
failur
exacerb
respond
medic
therapi
frequenc
exacerb
reduc
appropri
use
inhal
corticosteroid
bronchodil
vaccin
bronchodil
shortact
agonist
saba
shortact
muscarin
antagonist
sama
initi
empir
treat
ment
relief
breathless
exercis
limit
ic
potenti
advers
effect
includ
nonfat
pneumonia
peopl
copd
offer
oncedaili
lama
prefer
fourtim
daili
sama
peopl
stabl
copd
remain
breathless
exacerb
despit
use
shortact
bronchodil
requir
decis
made
commenc
regular
mainten
bronchodil
therapi
muscarin
antagonist
see
patient
whatev
age
abl
acquir
main
tain
adequ
inhal
techniqu
bronchodil
usual
best
administ
use
handheld
inhal
devic
includ
spacer
devic
appropri
patient
distress
disabl
dyspnoea
despit
maxim
therapi
use
inhal
consid
nebul
therapi
offer
choic
face
mask
mouth
piec
administ
nebul
therapi
unless
drug
specif
requir
mouthpiec
exampl
anticholinerg
drug
patient
advanc
copd
may
requir
mainten
oral
corticosteroid
withdrawn
follow
exac
bation
individu
monitor
develop
osteoporosi
given
appropri
prophylaxi
theophyllin
use
trial
saba
laba
unabl
use
inhal
therapi
need
monitor
plasma
level
interact
dose
theo
phyllin
prescrib
reduc
time
exacerb
macrolid
fluoroquinolon
antibiot
drug
known
interact
given
insuffici
evid
recommend
prophylact
antibiot
therapi
manag
stabl
copd
mucolyt
drug
therapi
consid
patient
chronic
cough
product
sputum
patient
remain
symptomat
monotherapi
treatment
intensifi
combin
therapi
differ
drug
class
agonist
theophyllin
anticholinerg
theophyllin
inappropri
oxygen
therapi
peopl
copd
may
depress
respir
ltot
indic
patient
copd
pao
less
kpa
sta
ble
pao
greater
kpa
less
kpa
stabl
one
secondari
polycythaemia
nocturn
hypoxaemia
oxygen
satur
arteri
blood
sao
less
time
peripher
oedema
pulmonari
hypertens
reap
benefit
ltot
patient
breath
supplement
oxygen
least
hour
per
day
ensur
elig
ltot
identifi
puls
oximetri
avail
health
care
set
assess
patient
ltot
compris
measur
arteri
blood
gase
two
occas
least
week
apart
patient
confid
diagnosi
copd
receiv
optimum
medic
manag
whose
copd
stabl
patient
warn
risk
fire
explos
told
smoke
use
oxygen
ambulatori
oxygen
therapi
consid
patient
ltot
wish
continu
oxygen
therapi
outsid
home
exercis
desatur
shown
improv
exercis
capac
andor
dyspnoea
oxi
gen
motiv
use
oxygen
adequ
treat
patient
chronic
hypercapn
respiratori
failur
requir
assist
ventil
exacerb
hypercapn
acidot
ltot
refer
specialist
centr
consider
longterm
niv
advanc
emphysema
occasion
treat
sur
geri
excis
larg
acquir
bulla
rare
lung
transplant
patient
copd
need
dental
care
classifi
follow
patient
low
risk
experi
dyspnoea
effort
normal
blood
ga
level
patient
receiv
dental
treatment
minor
modif
patient
moder
risk
experi
dyspnoea
effort
chronic
treat
bronchodil
recent
corticosteroid
pao
lower
medic
consult
advis
determin
level
control
diseas
dental
treatment
patient
high
risk
symptomat
copd
may
end
stage
poorli
respons
treatment
patient
medic
consult
essenti
dental
treatment
carri
patient
copd
best
treat
upright
posit
midmorn
earli
afternoon
sinc
may
becom
increasingli
dyspnoeic
laid
supin
may
difficult
use
rubber
dam
patient
mouthbreath
abl
toler
addit
obstruct
la
prefer
dental
treatment
bilater
mandibular
palat
inject
avoid
patient
copd
given
rel
analgesia
absolut
necessari
hospit
full
preoper
assess
cs
diazepam
midazolam
use
benzodiazepin
respiratori
depress
patient
given
ga
absolut
necessari
intraven
barbitur
contraind
secret
reduc
airway
patenc
lightli
anaesthet
patient
may
cough
contamin
area
lung
postop
respiratori
complic
preval
patient
preexist
lung
diseas
especi
prolong
oper
preoper
prepar
import
singl
factor
preoper
care
cessat
smok
ing
least
week
preoper
respiratori
infect
must
also
erad
sputum
first
sent
cultur
sensit
antimicrobi
amoxicillin
start
without
await
ing
result
medic
manag
copd
optim
prior
surgeri
ultim
clinic
decis
whether
proceed
surgeri
rest
consult
anaesthetist
consult
surgeon
take
account
comorbid
function
statu
patient
necess
surgeri
composit
assess
tool
american
societi
anesthesiologist
asa
score
system
lung
function
best
criteria
assess
patient
copd
surgeri
take
corticosteroid
treat
appropri
ate
precaut
ch
interact
theophyllin
drug
adrenalin
epinephrin
erythromycin
clindamycin
azithro
mycin
clarithromycin
ciprofloxacin
may
result
danger
high
level
theophyllin
ipratropium
caus
dri
mouth
guidelin
manag
copd
may
found
http
publicationsniceorgukchronicobstructivepulmonarydiseas
access
septemb
respiratori
virus
usual
spread
touch
airborn
transmiss
small
particl
micrometr
avoid
upper
respiratori
tract
defenc
mucociliari
elev
reach
lung
alveoli
rang
virus
caus
lower
respiratori
tract
infect
lrti
tabl
virus
eg
influenza
respiratori
syncyti
spread
upper
lower
respira
tori
tract
via
infect
respiratori
epithelium
lead
bacteri
superinfect
pneumon
pneumonia
mycoplasm
atyp
pneumonia
tuberculosi
tb
may
direct
infect
epidem
potenti
fatal
sever
acut
respiratori
syndrom
sar
caus
coronaviru
origin
china
spread
worldwid
bird
influenza
also
aros
epidem
similar
epidem
swine
influenza
eman
mexico
see
later
bacteri
infect
pneumonia
lung
abscess
also
result
materi
aspir
lung
usual
unilat
eral
aspir
other
result
frequent
lrti
seen
alcohol
drug
abus
well
comatos
patient
exogen
penetr
contamin
lung
result
trauma
eg
stab
wound
road
traffic
accid
surgeri
entamoeba
histolytica
occasion
caus
pneumonia
direct
extens
amoeb
liver
abscess
tabl
patient
endocard
septic
pelvic
jugular
thrombo
phlebiti
may
experi
lrti
acquir
haematogen
often
bilater
immunocompromis
person
eg
human
immunod
ficienc
virusacquir
immun
defici
syndrom
hivaid
transplant
recipi
peopl
bronchiectasi
cystic
fibrosi
also
suscept
respiratori
infect
rang
opportun
istic
microb
pneumocysti
jiroveci
p
carinii
exampl
com
mon
caus
potenti
fatal
pneumonia
immunocompromis
patient
especi
hivaid
ch
clinic
featur
lrti
vari
accord
part
respiratori
tract
mainli
affect
bronchiol
caus
rapid
respir
wheez
fever
dyspnoea
restrict
mainli
infant
bronchiti
caus
cough
wheez
sometim
dyspnoea
pneumonia
caus
cough
fever
rapid
respir
breathless
chest
pain
dyspnoea
shiver
antimicrobi
therapi
indic
particularli
pneumonia
antivir
highli
effect
oxygen
may
need
pneumococc
vaccin
indic
older
peopl
major
lrti
sever
ill
contraind
emerg
dental
treatment
ga
hazard
absolut
contraind
dental
treatment
defer
recoveri
limit
pain
relief
influenza
mainli
communitybas
infect
transmit
hous
hold
commun
healthcareassoci
influenza
infect
aris
healthcar
set
commonli
influenza
also
circul
commun
influenza
contagi
diseas
caus
influenza
viru
type
b
c
type
two
main
subtyp
caus
widespread
influenza
epidem
occasion
fatal
type
b
virus
gener
caus
region
outbreak
moder
sever
type
c
virus
minor
signific
person
spread
influenza
start
day
feel
sick
anoth
day
symptom
start
influenza
pre
vent
amelior
vaccin
autumn
especi
indic
older
peopl
cardiorespiratori
diseas
influenza
attack
virtual
whole
respiratori
tract
symptom
appear
suddenli
day
includ
fever
sore
throat
nasal
congest
headach
tired
dri
cough
muscl
pain
myalgia
peopl
recov
week
infect
lifethreaten
mainli
primari
influenz
viral
pneumonia
lead
sec
ondari
bacteri
pneumonia
exacerb
underli
condit
eg
pulmonari
cardiac
diseas
old
young
chronic
disord
like
suffer
complic
pneumonia
bronchiti
sinus
otiti
media
influenza
also
follow
depress
encephalopathi
myocard
myositi
pericard
rey
syndrom
transvers
myeliti
rest
mainten
fluid
intak
analges
antipyret
avoid
anc
alcohol
tobacco
help
reliev
symptom
aspirin
must
never
given
children
age
year
flulik
symptom
particularli
fever
caus
rey
syndrom
zanamivir
antivir
work
influenza
type
b
shorten
symptom
approxim
day
treatment
start
first
day
ill
antivir
drug
includ
amantadin
oseltamivir
rimantadin
may
help
use
restrict
mainli
immunocompromis
person
sinc
caus
advers
effect
influenza
sever
contagi
ill
emerg
den
tal
treatment
defer
recoveri
ga
hazard
absolut
contraind
influenza
type
subtyp
caus
ill
known
avian
influenza
bird
flu
bird
human
mani
anim
spe
cie
hpai
highli
pathogen
avian
influenza
viru
type
subtyp
caus
agent
enzoot
mani
bird
popul
especi
southeast
asia
spread
global
result
death
peopl
slaughter
mil
lion
chicken
vaccin
could
provid
protect
prepandrix
clear
use
european
union
recent
emerg
infect
similar
mani
respect
swine
influenza
common
pig
midwestern
unit
state
mexico
canada
south
america
europ
includ
uk
sweden
itali
kenya
china
taiwan
japan
part
eastern
asia
transmiss
swine
influenza
viru
pig
human
com
mon
produc
symptom
similar
influenza
outbreak
human
swine
flu
due
appar
new
strain
aris
reassort
produc
strain
human
avian
swine
virus
pass
human
human
antivir
agent
oseltamivir
may
help
vaccin
avail
outbreak
lifethreaten
febril
respiratori
infect
appear
origin
guangdong
china
name
sever
acut
respiratori
syndrom
sar
caus
newli
recogn
coronaviru
sarsassoci
coronaviru
sarscov
sar
spread
via
close
contact
mani
countri
across
world
accord
world
health
organ
peopl
worldwid
becam
sick
sar
cours
first
recogn
outbreak
die
incub
period
day
follow
high
fever
malais
headach
myalgia
peopl
also
experi
mild
upper
respiratori
symptom
day
lower
respiratori
sign
dri
cough
dyspnoea
potenti
progress
hypox
aemia
sar
caus
pneumonia
mortal
approach
particularli
older
immunocompromis
peopl
artifici
ventil
need
case
antivir
agent
oseltamivir
ribavirin
may
help
inactiv
vaccin
viral
bacteri
vector
vaccin
recombin
protein
dna
vaccin
well
attenu
vaccin
develop
sar
sever
ill
emerg
dental
treatment
defer
recoveri
ga
hazard
absolut
contraind
contact
suspect
sar
patient
care
hand
hygien
import
includ
handwash
soap
water
hand
visibl
soil
alcoholbas
handrub
may
use
altern
handwash
suspect
sar
patient
admit
hospit
infect
control
personnel
notifi
immedi
infect
control
measur
wwwcdcgovncidodhipiso
latisolathtm
access
septemb
includ
standard
precaut
eg
hand
hygien
healthcar
personnel
wear
eye
protect
patient
contact
contact
precaut
eg
gown
glove
contact
patient
environ
airborn
precaut
eg
isol
room
neg
pressur
rel
surround
area
use
filter
dispos
respir
person
enter
room
pneumonia
class
primari
occur
previous
healthi
individu
usual
lobar
call
secondari
follow
disord
previou
viral
respiratori
infect
aspir
ation
foreign
materi
lung
diseas
bronchiectasi
carcinoma
depress
immun
eg
alcohol
immunosuppress
aspir
ation
oral
bacteria
pneumonia
caus
cough
fever
rapid
respir
breathless
chest
pain
dyspnoea
shiver
complic
includ
lung
abscess
empyema
pu
pleural
caviti
import
avoid
alcohol
tobacco
use
analges
antipyret
reliev
symptom
broadspectrum
antimicrobi
al
given
promptli
empir
usual
includ
macrolid
azithromycin
clarithromycin
erythromycin
quinolon
moxiflox
acin
gatifloxacin
levofloxacin
doxycyclin
outpati
patient
cefuroxim
ceftriaxon
plu
macrolid
use
prophylaxi
includ
immun
influenza
pneumococci
pneumonia
sever
ill
emerg
dental
treatment
defer
recoveri
ga
hazard
absolut
contraind
ventilatorassoci
pneumonia
vap
discuss
later
legionellosi
bacteri
respiratori
infect
caus
one
famili
legionellacea
gramneg
aerob
bacilli
ubiquit
water
soil
particularli
prefer
warm
aquat
environ
term
legionnair
diseas
coin
result
outbreak
previous
unrecogn
respiratori
diseas
american
legion
meet
philadelphia
recogn
worldwid
mani
infect
contract
travel
abroad
particularli
spain
turkey
mediterranean
area
legionella
bacteria
found
natur
freshwat
environ
usual
insuffici
number
caus
diseas
legionella
grow
best
warm
water
hot
tub
cool
tower
hot
water
tank
larg
plumb
system
aircondit
system
larg
build
though
legionellacea
infect
caus
legionella
pneumophila
diseas
contract
inhal
contamin
mist
vapour
mainli
approxim
aerosol
infect
water
aircondit
system
hotwat
system
humidifi
nebul
shower
spa
pool
outbreak
mostli
link
aerosol
sourc
commun
cruis
ship
hotel
like
sourc
whirlpool
spa
air
condit
unit
larg
build
potabl
drink
water
system
water
use
bath
risk
factor
includ
exposur
recent
travel
overnight
stay
outsid
home
outbreak
travelassoci
legionellosi
infrequ
identifi
case
thought
associ
recent
travel
whirlpool
spa
recent
repair
mainten
work
domest
plumb
system
illhealth
alcohol
use
chronic
kidney
diseas
diabet
immun
defect
liver
diseas
malign
smoke
ill
mainli
affect
male
smoker
heavi
drinker
older
peopl
immunocompromis
also
vulner
travel
especi
middleag
older
tourist
confer
busi
group
possibl
tired
age
mani
young
peopl
expos
infect
becom
seroposit
remain
healthi
evid
persontoperson
transmiss
legionellosi
legionellosi
manifest
one
two
clinic
syndrom
tabl
legionnair
diseas
typic
lobular
type
pneumonia
fatal
fortun
rare
infect
rang
discret
patch
inflamm
consolid
involv
whole
lobe
pontiac
fever
milder
usual
subsid
rapidli
often
treatment
peopl
test
legionnair
diseas
includ
pneumonia
follow
group
legionella
commonli
found
environ
clinic
isol
necessari
interpret
find
environment
investig
diagnosi
rapid
urin
molecular
test
l
pneumophila
antigen
cultur
respiratori
secret
select
media
sensit
specif
diagnost
test
shown
tabl
pontiac
fever
selflimit
ill
case
recov
within
week
benefit
antibiot
treatment
overal
mortal
legionnair
diseas
may
high
older
peopl
immunocompromis
erythromycin
standard
treatment
cephalosporin
altern
legionella
speci
present
roughli
twothird
potabl
water
sampl
collect
domest
institut
tap
drink
fountain
similar
percentag
dental
unit
water
dental
unit
often
higher
bacteri
concentr
ch
report
legionella
infect
dental
unit
water
line
antibodi
occasion
frank
infect
demonstr
dental
staff
least
one
patient
appear
contract
die
infect
eman
dental
practic
prevent
crucial
involv
ch
gener
aspect
tuberculosi
tb
infect
caus
mycobacteria
affect
approxi
mate
onethird
world
popul
billion
peopl
major
global
health
problem
million
peopl
die
annu
alli
tb
disproportion
affect
poorest
person
high
incom
develop
countri
highincom
countri
human
tb
aris
mycobacterium
tuberculosi
transmit
person
person
air
tb
usual
affect
lung
initi
pulmonari
tb
also
involv
brain
kidney
spine
part
victorian
time
second
world
war
mycobacterium
bovi
infect
infect
cow
milk
bovin
btb
major
caus
morbid
mortal
clinic
patholog
indistin
guishabl
infect
caus
tuberculosi
cattletest
slaughter
programm
becam
compulsori
incid
tb
cattl
substanti
reduc
tuberculosi
bovi
cow
milk
virtual
elimin
highincom
countri
tuberculin
test
cattl
pasteur
milk
develop
world
mani
cattl
still
tb
btb
still
seen
btb
also
increas
highincom
countri
last
two
dec
ade
infect
rate
badger
transmiss
cattl
may
explain
tb
spread
touch
drink
glass
dish
sheet
cloth
usual
transmit
infect
sputum
typic
close
contact
famili
member
unlik
transmit
ted
normal
social
contact
tb
present
occup
risk
healthcar
profession
includ
dental
staff
one
outbreak
drugresist
tb
new
york
involv
least
patient
contract
tb
one
hospit
nearli
patient
also
hivposit
young
male
hispan
african
heritag
tb
transmit
pa
senger
longhaul
airlin
flight
risk
transmit
tb
though
air
circul
low
higheffici
particu
late
air
hepa
filter
newer
commerci
aircraft
type
use
hospit
respiratori
isol
room
inde
number
time
air
clean
hour
exce
recommend
hospit
isol
room
subsaharan
africa
highest
rate
activ
tb
per
capita
driven
primarili
hiv
epidem
absolut
number
case
highest
asia
india
china
great
est
burden
diseas
global
usa
western
european
countri
major
case
occur
foreignborn
resid
recent
immigr
countri
tubercu
losi
endem
immunocompromis
peopl
diabet
sever
immuno
defici
patient
like
hivaid
south
african
hivaid
also
tb
patient
prison
institut
risk
tb
also
mainli
affect
medic
neglect
person
vagrant
alcohol
intraven
drug
abus
older
homeless
peopl
main
group
increas
risk
infect
therefor
includ
peopl
resourcepoor
immunoincompet
especi
tb
develop
countri
particularli
widespread
increas
highest
rise
incid
southeast
asia
subsaharan
africa
eastern
europ
highincom
countri
incid
also
rise
probabl
worsen
social
depriv
homeless
immigr
hiv
infect
intra
venou
drug
abus
common
london
devel
ope
world
seen
especi
immigr
indian
subcontin
africa
south
asia
increas
appear
result
develop
tb
diseas
individu
al
may
infect
time
new
infect
acquir
uk
result
travel
countri
tb
common
london
account
highest
proport
case
uk
follow
west
midland
region
born
outsid
uk
mainli
origin
south
asia
subsaharan
africa
rise
number
tb
case
compar
well
increas
drug
resist
inform
tb
includ
statist
found
http
wwwhpaorgukpublicationsinfectiousdiseasestuberculosi
http
wwwtbfactsorgtbstatisticshtml
access
septemb
initi
infect
tb
usual
subclin
infect
develop
overt
diseas
half
manifest
within
year
primari
tb
remaind
develop
postprimari
diseas
inhal
mycobacteria
may
caus
subpleur
lesion
primari
lesion
lesion
region
lymph
node
primari
complex
bodi
defenc
usual
local
mycobacteria
though
remain
viabl
infect
person
obvious
ill
unlik
know
infect
latent
tabl
latent
tb
infect
ltbi
usu
alli
becom
activ
mani
year
bodi
defenc
becom
weaken
box
howev
activ
tb
develop
shortli
mycobacteria
enter
bodi
bodi
defenc
impair
age
drug
alcohol
abus
hivaid
also
massiv
infec
tion
acut
activ
tb
result
typic
caus
chronic
product
cough
haemoptysi
weight
loss
night
sweat
fever
erythema
nodosum
may
associ
extrapulmonari
tb
less
common
may
appear
glandular
involv
neck
elsewher
less
infecti
pulmonari
tb
lymph
node
tb
may
lead
lymphadenopathi
caseat
node
pressur
symptom
exampl
bronchi
postprimari
tb
follow
reactiv
old
primari
pulmonari
lesion
result
featur
rang
chronic
fibrot
lesion
fulmin
tubercul
pneumonia
pulmonari
lesion
may
extend
lead
pleural
effus
reactiv
progress
primari
tb
may
also
result
widespread
haematogen
dissemina
tion
mycobacteria
miliari
tb
multipl
lesion
may
involv
central
nervou
system
bone
joint
cardiovascular
gastroint
tinal
genitourinari
system
clinic
present
tb
thu
variabl
depend
extent
spread
organ
involv
frequent
pass
unrecog
nize
long
mortal
high
similar
ill
tb
may
also
caus
atyp
nontub
culou
mycobacteria
avium
complex
mac
see
diagnosi
tb
suggest
histori
confirm
physic
examin
massiv
rais
erythrocyt
sediment
rate
esr
posit
tuberculin
skin
test
tst
mantoux
heaf
test
delay
hypersensit
reaction
protein
tuberculosi
purifi
protein
deriv
ppd
chest
imag
hypersensit
develop
week
infect
detect
convers
tst
neg
posit
tst
neither
sensi
tive
specif
posit
mantoux
reaction
indic
previou
immu
nizat
bcg
bacil
live
attenu
bovi
current
infect
necessarili
diseas
chest
radiographi
may
show
scar
hilar
lymphadenopathi
comput
tomographi
ct
may
show
area
calcif
highlight
tubercul
abscess
smear
cultur
sputum
blood
laryng
swab
bronchoalveolar
lavag
gastric
aspir
pleural
fluid
may
test
mycobacteria
polymeras
chain
reaction
pcr
techniqu
greatli
accel
ate
diagnosi
speciat
though
ziehlneelsen
auramin
rhodamin
microbi
stain
still
use
mycobacteria
growth
indic
tube
mgit
system
give
result
earli
day
blood
assay
tuberculosi
bamt
may
posit
interferongamma
releas
assay
igra
peopl
year
posit
igra
igra
use
place
addit
tst
igra
measur
immun
reactiv
tuberculosi
white
blood
cell
person
infect
tuberculosi
releas
interferongamma
mix
tuberculosi
antigen
posit
test
result
sug
gest
tuberculosi
infect
like
neg
result
suggest
infect
unlik
latent
infect
ltbi
diagnos
either
tuberculin
skin
test
igra
specif
igra
give
result
within
hour
use
biolog
therapi
given
rheumatoid
arthriti
inflammatori
bowel
diseas
prior
bcg
vacci
nation
caus
falseposit
igra
test
result
informa
tion
igra
avail
http
wwwcdcgovtbpubl
factsheetstestingigrahtm
access
septemb
activ
tb
diagnos
sputum
microscopi
cultur
liquid
medium
subsequ
drugsuscept
test
nucleic
acid
peopl
test
tb
includ
symp
tom
close
daytoday
contact
activ
tb
diseas
famili
member
friend
cowork
hiv
infect
aid
lower
immun
requir
employ
school
treat
biolog
agent
top
prioriti
tb
control
programm
identifi
give
complet
treatment
patient
activ
diseas
tb
notifi
abl
diseas
contact
trace
import
aspect
limit
spread
treatment
antibiot
indic
peopl
sick
tb
infect
sick
close
contact
infecti
tb
case
treatment
symptomat
sputumposit
patient
institut
soon
possibl
combin
chemotherapi
usual
isoniazid
plu
rifampicin
plu
pyrazinamid
ethambutol
month
continu
daili
isoniazid
rifampicin
month
treatment
asymptomat
patient
believ
infect
contact
unwel
includ
isoniazid
month
isoniazid
rifampicin
month
rifapentin
longact
rifampicin
use
weekli
fluoroquinolon
moxifloxacin
may
also
act
tb
may
resist
one
one
antibiot
current
given
potenti
risk
drugresist
tb
present
treatment
usual
start
isoniazid
rifampicin
pyrazinamid
ethambutol
quinolon
gatifloxacin
moxifloxacin
month
isoniazid
rifampicin
month
antitubercul
drug
tabl
potenti
seriou
advers
effect
requir
care
monitor
patient
complianc
consid
poor
directli
observ
therapi
dot
drug
dispens
taken
presenc
healthcar
profe
sional
may
indic
new
drug
horizon
immun
use
bcg
advoc
schoolchildren
highrisk
individu
healthcar
profession
although
efficaci
question
new
vaccin
develop
chemoprophylaxi
isoniazid
rifampicin
indic
number
situat
box
tb
becom
resist
drug
use
treat
particularli
drug
misus
mismanag
may
occur
exampl
develop
countri
approxim
case
multi
ple
antibioticresist
term
multidrugresist
tuberculosi
mdrtb
uk
small
minor
current
fall
categori
number
case
increas
mdrtb
defin
resist
rifampicin
isoniazid
may
atyp
presenta
tion
infect
dissemin
peopl
tb
worldwid
mdrtb
eastern
europ
high
preval
mdrtb
seen
mainli
peopl
hivaid
hivaid
african
bedaquilin
new
antitubercular
agent
first
activ
agent
tuberculosi
regist
sinc
extens
drugresist
tuberculosi
xdrtb
rare
type
mdrtb
resist
isoniazid
rifampin
also
fluoroquinolon
least
one
three
inject
secondlin
drug
ie
amikacin
kanamycin
capreomycin
xdrtb
special
concern
immunocompromis
peopl
eg
hivaid
like
develop
tb
higher
risk
death
develop
xdrtb
often
encount
peopl
eastern
europ
russia
africa
transmit
healthcar
facil
seen
worldwid
essenti
untreat
though
capreomycin
use
effect
treat
mdrtb
hivposit
individu
total
drugresist
tb
report
initi
india
iran
itali
spread
despit
denial
disquiet
chronic
ulcer
usual
tongu
dorsum
main
oral
manifest
tb
result
cough
infect
sputum
pulmonari
tb
includ
hivinfect
person
tb
rare
case
usual
middleag
male
may
result
neglect
symptom
default
treatment
occasion
diagnosi
made
biopsi
ulcer
granuloma
seen
microscop
acidfast
bacilli
rare
seen
oral
biopsi
even
help
special
stain
unfix
materi
also
sent
cultur
possibl
tubercul
cervic
lymphadenopathi
next
common
form
infect
particularli
com
mon
among
south
asia
tb
lymphaden
pain
less
sever
enlarg
mat
node
system
symptom
present
minor
pulmonari
mani
festat
radiographi
fig
diagnosi
reli
tuberculin
test
posit
tubercul
non
tubercul
mycobacteri
cervic
lymphaden
person
lymphadenop
athi
recent
convers
neg
posit
tuberculin
test
suspect
mycobacteri
infect
prompt
biopsi
eg
fineneedl
aspir
biopsi
cultur
histo
logic
confirm
pcr
improv
diagnosi
cultur
must
wait
week
result
oral
complic
antitubercular
therapi
rare
rifabutin
rifampicin
caus
red
saliva
pulmonari
tb
high
infect
shown
case
tuber
culou
infect
extract
socket
cervic
lymphaden
patient
treat
infect
member
staff
dental
clinic
dental
staff
hivposit
work
dental
clinic
hivinfect
person
new
york
die
tb
con
tract
occup
transmiss
mdrtb
two
dental
worker
may
occur
hiv
dental
clinic
infect
control
thu
import
staff
tb
usual
preclud
occup
treat
manag
patient
tb
depend
upon
level
poten
tial
infect
tabl
patient
open
pulmonari
tb
con
tagiou
dental
treatment
thu
best
defer
infect
treat
treatment
appropri
drug
week
drasti
calli
reduc
infect
patient
pulmonari
tb
patient
open
pulmonari
tb
must
given
dental
treatment
special
pre
caution
use
prevent
releas
mycobacteria
air
remov
present
stop
inhal
person
reduct
splatter
aerosol
minim
cough
ing
avoid
ultrason
instrument
use
rubber
dam
import
improv
ventil
ultraviolet
germicid
light
new
mask
person
respir
person
protect
devic
hepa
filter
indic
fig
mycobacteria
resist
disinfect
heat
steril
must
use
la
safe
satisfactori
rel
analgesia
contraind
risk
contamin
apparatu
ga
also
contraind
dental
treatment
risk
contamina
tion
anaesthet
apparatu
impair
pulmonari
function
aminoglycosid
streptomycin
enhanc
activ
neuromuscular
block
drug
larg
dose
may
alon
caus
myasthen
syndrom
possibl
drug
interact
shown
tabl
factor
alcohol
intraven
drug
use
ch
hepat
ch
hiv
diseas
ch
may
also
influenc
dental
manag
mycobacteria
tuberculosi
mott
wide
distribut
water
soil
anim
human
rare
caus
diseas
sever
mott
infect
seen
howev
individu
predispos
defect
interferongamma
ifngamma
pathway
mycobacterium
abscessu
bacterium
found
water
soil
dust
known
contamin
medic
product
includ
medic
devic
healthcareassoci
abscessu
caus
vari
eti
infect
usual
skin
also
caus
lung
infec
tion
person
variou
chronic
lung
diseas
increasingli
recogn
opportunist
pathogen
cystic
fibrosi
cf
patient
persontoperson
transmiss
atyp
mycobacteria
import
acquisit
infect
except
skin
infect
rare
occas
mott
skin
infect
follow
tattoo
contamin
tattoo
ink
mani
peopl
becom
infect
har
bour
mott
respiratori
secret
without
symptom
evid
diseas
individu
respiratori
diseas
mott
readili
infect
other
therefor
need
isol
mott
gener
infecti
other
infect
abscessu
usual
caus
inject
con
tamin
substanc
invas
medic
procedur
employ
contamin
equip
materi
infect
also
occur
accident
injuri
wound
contamin
soil
littl
risk
transmiss
person
person
mac
complex
scrofulaceum
kansasii
possibl
caus
tubercul
cervic
lymphaden
mac
may
also
infect
lung
similar
tb
skin
lymph
node
lung
diseas
also
caus
occasion
kansasii
mainli
middleag
older
person
underli
chronic
lung
condit
fortuitum
chelona
may
caus
skin
wound
infect
abscess
frequent
associ
trauma
surgeri
marinum
may
caus
swim
pool
granuloma
nodular
lesion
may
ulcer
usual
extrem
ulceran
may
produc
chronic
ulcer
skin
lesion
usual
extrem
abscessu
skin
infect
present
swollen
pain
area
usual
red
warm
tender
touch
also
develop
boil
pustul
featur
abscessu
infect
fever
chill
muscl
ach
malais
cervic
lymphaden
due
mac
scrofulaceum
kansasii
may
affect
otherwis
healthi
young
children
commonli
pre
school
femal
unilater
cervic
lymphadenopathi
typic
submandibular
jugulodigastr
node
may
form
cold
abscess
mott
usual
caus
children
year
tb
common
older
patient
absenc
fever
tuber
culosi
posit
tuberculin
test
fail
respons
convent
antimicrobi
highli
suggest
mott
definit
diagnosi
smear
cultur
pcr
biopsi
materi
obtain
fineneedl
aspir
remov
node
treatment
base
result
laboratori
test
identifi
appropri
antibiot
prevent
treatment
close
contact
person
diseas
caus
mott
need
mott
resist
standard
antitubercular
medic
though
possibl
clarithromycin
clofazimin
may
effect
excis
affect
node
usual
recommend
therapi
water
dental
unit
may
contain
mott
speci
mycobacteri
prolifer
biofilm
may
explain
extent
contamin
ch
aspir
syndrom
condit
foreign
substanc
inhal
lung
consequ
rang
asphyxia
infect
lung
abscess
dental
restor
frag
ment
teeth
plaqu
gastric
content
materi
may
aspir
especi
materi
enter
pharynx
particularli
cough
reflex
impair
reason
commonli
aspir
syndrom
involv
oral
gastric
content
associ
gastrooesophag
reflux
diseas
gord
swallow
dysfunct
ch
neurolog
disord
structur
abnorm
pharyng
pouch
cricopharyng
dy
function
involv
cricopharyng
muscl
spasm
achalasia
superior
oesophag
sphincter
seen
infant
normal
suck
reflex
incoordin
swallow
po
sibli
secondari
delay
develop
cerebr
palsi
anatom
disord
cleft
palat
pharyng
pouch
oesophag
atresia
tracheooesophag
fistula
duoden
obstruct
malrot
motil
disord
achalasia
may
aspir
risk
infirm
older
patient
also
risk
aspir
especi
bedbound
neurolog
disord
isol
superior
laryng
nerv
damag
vocal
cord
paralysi
cerebr
palsi
muscular
dystrophi
rileyday
syndrom
famili
dysautonomia
associ
increas
risk
aspir
ventilatorassoci
pneumonia
vap
defin
center
diseas
control
prevent
cdc
present
chest
radiograph
show
new
progress
infiltr
consolid
cavit
pleural
effus
conjunct
either
new
onset
purul
sputum
chang
charact
sputum
organ
isol
blood
isol
aetiolog
agent
specimen
obtain
via
suction
aspir
endotrach
tracheostomi
tube
major
rout
acquir
endem
vap
oropharyng
colo
nizat
endogen
flora
exogen
acquir
pathogen
intens
care
unit
vap
commonli
report
health
careacquir
infect
patient
receiv
mechan
ventil
preval
rate
consist
rang
mortal
rate
vap
least
doubl
patient
without
vap
rang
infect
caus
multidrugresist
gramneg
pathogen
healthcar
infect
control
practic
advisori
committe
cdc
develop
guidelin
prevent
vap
includ
strategi
aim
prevent
aspir
contamin
oral
gastric
materi
eg
rais
head
bed
drain
subglott
secret
intervent
alter
bacteri
coloniza
tion
stomach
eg
stress
ulcer
prophylaxi
select
digest
decontamin
mouth
oral
hygien
suction
provi
sion
moistur
lip
oral
mucosa
plu
toothbrush
may
import
prevent
vap
also
strategi
manag
ing
ventil
circuit
eg
replac
ventil
circuit
use
close
rather
open
suction
use
heat
moistur
exchang
oppos
heat
circuit
technolog
lung
abscess
local
infect
lead
cavit
necro
si
case
result
aspir
foreign
materi
develop
pneumonia
caus
infect
staph
aureu
klebsiella
pneumonia
bronchial
obstruct
carcinoma
anoth
import
caus
symptom
resembl
suppur
pneumonia
risk
infect
spread
local
lead
via
septicaemia
brain
abscess
diagnosi
rest
mainli
chest
radiograph
may
sometim
show
cavit
fluid
level
antimicrobi
chemotherapi
postur
drainag
relief
bronchoscopi
obstruct
indic
wellrecogn
caus
lung
abscess
inhal
tooth
fragment
restor
rare
endodont
instrument
undertak
endodont
cement
restor
inlay
crown
rubber
dam
protect
devic
alway
use
avoid
danger
inhal
lung
abscess
may
also
result
aspir
oral
bacteria
particularli
anaerob
especi
infirm
older
patient
intub
main
danger
dentistri
ga
particularli
inadequ
throat
pack
use
patient
inhal
tooth
frag
ment
dental
instrument
must
chest
radiograph
later
posteroanterior
necessari
bronchoscopi
loeffler
syndrom
appear
allerg
reaction
usual
parasit
worm
ascari
lumbricoid
drug
sulphonamid
manifest
pulmonari
infiltr
abnorm
chest
radio
graph
eosinophilia
eosinophil
pneumonia
diseas
usual
clear
spontan
sarcoidosi
name
skin
lesion
resembl
sarcoma
multisystem
granulomat
disord
seen
commonli
young
adult
femal
northern
europ
especi
peopl
african
heritag
aetiolog
unclear
propionibacterium
acn
p
granulosum
implic
associ
report
exposur
inorgan
particl
insecticid
mould
occup
firefight
metalwork
serum
sam
ple
contain
antibodi
direct
mycobacterium
tuberculosi
antigen
sarcoidosi
associ
butyrophilinlik
gene
chromosom
thelper
cell
releas
augment
macrophag
tumour
necrosi
factor
alpha
releas
regulatori
cell
caus
limit
impair
cellmedi
immun
respons
partial
anergi
obviou
special
suscept
infect
sarcoidosi
affect
thorax
protean
manifest
involv
virtual
tissu
tabl
sarcoid
typi
calli
caus
syndrom
fever
bilater
hilar
lymphadenopathi
arthralgia
erythema
nodosum
especi
around
ankl
fig
common
present
may
includ
pulmonari
infiltr
impair
respiratori
effici
cough
dyspnoea
sever
case
acut
uveiti
progress
blind
suscept
lymphoma
suggest
confirm
vagu
protean
manifest
sarcoidosi
diagnos
presenc
suggest
clinic
featur
help
investig
includ
chest
radiographi
enlarg
hilar
lymph
node
rais
serum
angiotensinconvert
enzym
sace
tabl
acut
diseas
insensit
nonspecif
poor
guid
therapi
posit
citrat
gadolinium
positron
emi
sion
tomographi
pet
scan
labial
salivari
gland
transbronchi
biopsi
histolog
evid
noncas
epithelioid
cell
granuloma
except
syndrom
classic
clini
cal
diagnosi
fdeoxyglucos
pet
help
identifi
site
biopsi
nonspecif
find
may
includ
mild
anaemia
leukopenia
eosinophilia
hypergammaglobulinaemia
rais
esr
low
serum
albumin
hypercalcaemia
common
extraren
produc
tion
activ
vitamin
result
renal
damag
alkalin
phosphatas
lysozym
adenosin
deaminas
level
rais
hepat
sarcoidosi
evid
impair
delay
hypersensit
reaction
antigen
may
use
kveim
skin
test
use
half
patient
sarcoidosi
remit
within
year
remit
year
patient
minor
symptom
usual
need
treatment
corticosteroid
sometim
azathioprin
methotrex
tetracyclin
hydroxychloroquin
infliximab
etan
cept
given
activ
organ
diseas
ocular
diseas
progr
sive
lung
diseas
hypercalcaemia
cerebr
involv
biopsi
minor
salivari
gland
frequent
show
noncas
granuloma
associ
featur
sarcoidosi
par
ticularli
hilar
lymphadenopathi
import
diagnost
find
ing
may
obviat
invas
procedur
sarcoidosi
involv
oral
tissu
predilect
salivari
gland
asymptomat
swell
parotid
gland
cervic
node
less
frequent
lip
may
accompani
system
diseas
superfici
deepseat
red
submucos
nodul
may
develop
intraor
lip
nontend
wellcircumscrib
brownishr
violac
nodul
superfici
ulcer
also
report
oral
lip
lesion
may
occasion
preced
system
involv
enlarg
major
salivari
gland
case
xerostomia
associ
salivari
lacri
mal
gland
enlarg
fever
uveiti
known
uveoparotid
fever
heerfordt
syndrom
salivari
swell
may
also
seen
featur
heerfordt
syndrom
salivari
gland
swell
usual
resolv
treatment
sarcoidosi
may
take
year
facial
palsi
cranial
neuropathi
may
seen
also
associ
syndrom
ssa
ssb
serum
autoantibodi
found
rare
associ
thyroid
addison
diseas
syndrom
sarcoidosi
tass
syndrom
group
patient
histolog
cal
featur
sarcoid
one
site
mouth
gingiva
system
manifest
patient
may
ultim
develop
less
systemat
diseas
major
probabl
isol
lesion
case
exog
enou
caus
granulomat
reaction
found
regard
sarcoidlik
reaction
orofaci
granulomatosi
treat
ment
unnecessari
howev
patient
kept
observa
tion
long
possibl
manag
patient
system
sarcoidosi
may
includ
con
sider
respiratori
impair
uveiti
visual
impair
renal
diseas
jaundic
corticosteroid
treatment
la
safe
satisfactori
cs
contraind
re
piratori
impair
ga
given
hospit
lung
cancer
common
cancer
highincom
countri
male
frequent
affect
adult
urban
cigarettesmok
bronchogen
carcinoma
account
primari
lung
cancer
also
becom
increasingli
common
women
increas
tobacco
use
extent
mortal
rate
two
sex
becom
almost
equal
metastas
cancer
elsewher
also
frequent
found
lung
recurr
cough
haemoptysi
dyspnoea
chest
pain
recurr
chest
infect
predomin
featur
local
infiltr
may
caus
pleural
effus
lesion
cervic
sympathet
chain
horner
syndrom
brachial
neuriti
recurr
laryng
nerv
palsi
obstruct
superior
vena
cava
facial
cyanosi
oedema
superior
vena
cava
syndrom
mani
nonmetastat
extrapulmonari
effect
bron
chogen
carcinoma
exampl
weight
loss
anorexia
fingerclub
neuromyopathi
thrombos
thrombophleb
migran
muscl
weak
variou
skin
manifest
ectop
hormon
product
antidiuret
hormon
adrenocorticotrop
hormon
parathyroid
hormon
thyroidstimul
hormon
metastas
bronchogen
cancer
common
typic
form
brain
may
manifest
headach
epilepsi
hemi
plegia
visual
disturb
liver
hepatomegali
jaundic
ascit
bone
pain
swell
patholog
fractur
diagnosi
base
histori
physic
examin
support
radiographi
ct
magnet
reson
imag
mri
sputum
cytolog
bronchoscopi
biopsi
spiral
ct
appear
detect
tumour
earli
stage
overal
surviv
rate
radiotherapi
common
treatment
patient
suitabl
surgeri
even
surviv
chemotherapi
disappoint
except
smallcel
carcinoma
dental
treatment
la
uncompl
cs
prefer
avoid
ga
matter
specialist
manag
hospit
patient
often
impair
respiratori
function
esp
cialli
lobectomi
pneumonectomi
along
muscl
weak
myasthen
syndrom
eatonlambert
syndrom
make
patient
unduli
sensit
action
muscl
relax
make
ga
hazard
oral
cancer
may
associ
lung
cancer
vice
versa
develop
later
stage
ch
synchron
metachron
primari
tumour
must
alway
rule
metastas
occasion
affect
orofaci
region
caus
enlarg
lower
cervic
lymph
node
epulislik
softtissu
swell
labial
hypoaesthesia
paraesthesia
jaw
soft
palat
pigment
rare
earli
oral
manifest
lung
cancer
fairli
common
caus
death
dental
techni
cian
unknown
whether
due
smoke
alon
dust
inhal
cystic
fibrosi
cf
one
common
fatal
hereditari
di
order
inherit
autosom
recess
trait
incid
birth
common
inherit
error
metabol
seen
mainli
peopl
european
descent
gene
respons
chromosom
cf
caus
defect
cystic
fibrosi
transmembran
conduct
regul
cftr
protein
appear
part
cyclic
adenosin
monophosph
camp
regul
chlorid
channel
regul
cl
na
transport
across
epitheli
membran
ion
channel
intracellular
fluid
flow
sweat
digest
mucu
gland
basic
defect
cf
abnorm
chlorid
ion
transport
across
cell
membran
nearli
exocrin
gland
blockag
salt
water
movement
cell
result
cell
line
lung
pancrea
organ
produc
abnorm
thick
sticki
mucu
obstruct
airway
variou
gland
especi
respiratori
tract
pancrea
involv
gland
lung
pancrea
intestin
gland
intrahepat
bile
duct
gallbladd
submaxillari
sweat
gland
may
becom
obstruct
viscid
solid
eosino
philic
materi
recurr
respiratori
infect
result
persist
product
cough
bronchiectasi
lung
becom
infect
varieti
organ
includ
staph
aureu
haemophilu
influenza
pseudomona
aeruginosa
strep
pneumonia
burkholderia
cepacia
sometim
mycos
mycobacteria
mycobacterium
abscessu
nontubercul
mycobacterium
increasingli
recogn
opportunist
pathogen
cf
patient
viral
infect
mea
sle
sever
sequela
pancreat
duct
obstruct
lead
pancreat
insuffici
malabsorpt
bulki
frequent
foulsmel
fatti
stool
gallston
diabet
cirrhosi
pancreat
may
result
sinus
common
growth
frequent
stunt
mutat
also
caus
con
genit
bilater
absenc
va
deferen
fertil
impair
male
cf
women
fertil
may
impair
viscid
cervic
secret
mani
women
carri
pregnanc
term
patient
high
concentr
sodium
sweat
also
reflect
saliva
sweat
test
show
sodium
chlorid
valu
mmoll
consid
posit
mmoll
equivoc
less
mmoll
neg
physiotherapi
postur
drainag
crucial
import
clearanc
sputum
help
water
aerosol
bronchodila
tor
terbutalin
salbutamol
mucolyt
carbocistein
methyl
cystein
dornas
alfa
question
effect
treatment
ivacaftor
cftr
potenti
improv
chlorid
transport
ion
channel
amoxicillin
flucloxacillin
effect
prophylact
antimicrobi
al
may
given
aerosol
vaccin
measl
whoop
ing
cough
influenza
import
low
fat
intak
adequ
vitamin
oral
pancreat
enzym
replac
pancreatin
also
necessari
doublelung
heartlung
transplant
may
eventu
becom
necessari
sinus
common
cf
patient
recurr
sinus
nasal
polyp
major
salivari
gland
may
enlarg
hyposali
vation
sometim
occur
lowfat
highcarbohydr
diet
dri
mouth
may
predispos
cari
enamel
hypoplasia
black
stain
may
seen
dental
develop
erupt
delay
tetracyclin
stain
teeth
common
rare
seen
pancreatin
may
caus
oral
ulcer
held
mouth
la
satisfactori
cs
usual
contraind
poor
respiratori
function
ga
contraind
respiratori
function
poor
lung
diseas
bronchiectasi
liver
diseas
diabet
may
complic
treatment
bronchiectasi
dilat
distort
bronchi
caus
includ
congenit
defect
consid
patient
includ
cystic
fibrosi
kartagen
syndrom
defici
collagen
defect
eg
marfan
syndrom
identifi
underli
caus
adult
children
damag
dilat
bronchi
lose
ciliat
epithelium
therefor
mucu
tend
pool
caus
recurr
lrti
typic
strep
pneumonia
haemophilu
influenza
pseudomona
aeruginosa
overproduct
sputum
purul
exacerb
cough
especi
exercis
lie
finger
club
typic
featur
recurr
episod
bronchiti
pneumonia
pleurisi
haemoptysi
uncommon
advanc
bronchiectasi
chest
pain
dyspnoea
cyanosi
respiratori
failur
may
develop
complic
may
includ
cerebr
abscess
amyloid
diseas
chest
radiographi
pulmonari
function
test
requir
high
resolut
ct
hrct
use
postur
drainag
import
antimicrobi
amoxicillin
cephalosporin
ciprofloxacin
given
acut
exacerb
longterm
mainten
treatment
ga
avoid
possibl
contraind
acut
phase
worker
expos
airborn
particl
may
develop
pulmonari
diseas
pneumoconiosi
rang
benign
eg
siderosi
malig
nant
mesothelioma
asbestosi
see
appendix
pneumoconiosi
caus
signific
incapac
ga
may
contraind
physician
contact
treatment
berylliosi
may
hazard
dental
technic
laboratori
lung
cancer
frequent
respiratori
complic
follow
surgic
oper
ga
includ
segment
lobar
pulmonari
collaps
infect
common
abdomin
surgeri
preexist
respiratori
diseas
smoke
see
also
ch
signifi
cantli
reduc
smoke
cessat
preoper
physiotherapi
bronchodil
salbutamol
postop
pulmonari
infect
develop
sputum
sent
cultur
physiotherapi
antibiot
given
common
microbi
caus
strep
pneumonia
haemophilu
influenza
case
suitabl
antibiot
includ
amoxicillin
erythromycin
hospit
infect
may
includ
microorgan
mrsa
klebsiella
pseudomona
gramneg
bacteria
inhal
aspir
gastric
content
caus
pulmonari
oedema
may
fatal
mendelson
syndrom
like
ga
given
patient
stomach
empti
hiatu
hernia
last
trimest
pregnanc
prevent
ensur
stomach
empti
preoper
ana
thetist
pass
endotrach
tube
antacid
blocker
cimetidin
ranitidin
may
given
mouth
pre
oper
lower
gastric
acid
gastric
content
aspir
pharynx
larynx
must
care
suck
system
corticosteroid
recommend
probabl
reduc
mortal
respiratori
distress
prematur
infant
may
caus
immatur
surfactantproduc
cell
alveoli
fail
expand
fulli
necessit
endotrach
intub
mani
week
may
turn
result
midfac
hypoplasia
palat
groov
cleft
defect
primari
dentit
oral
effect
may
seen
prolong
use
orogastr
feed
tube
degre
subsequ
growth
correct
deform
current
unknown
though
palat
groov
typic
regress
age
year
use
soft
endotrach
tube
obviat
problem
present
best
mean
avoid
palat
groov
appear
use
intraor
acryl
plate
stabil
tube
protect
palat
acut
respiratori
distress
syndrom
ard
sequel
sever
type
pulmonari
injuri
infect
includ
oral
viridan
streptococci
patient
endstag
pulmonari
diseas
consid
potenti
transplant
usual
use
lung
braindead
organ
donor
combin
ciclosporin
azathioprin
glucocorticoid
usu
alli
given
lifelong
immunosuppress
prevent
tcell
alloim
mune
reject
respons
inhal
nitric
oxid
modul
pulmonari
vascular
tone
via
smooth
muscl
relax
improv
ventilationperfus
match
oxygen
diseas
lung
earli
graft
failur
follow
lung
transplant
describ
variou
investi
gator
reimplant
oedema
reperfus
oedema
primari
graft
failur
allograft
dysfunct
patholog
entiti
diffus
alveolar
damag
see
also
chapter
meticul
presurgeri
oral
assess
requir
dental
treatment
must
undertaken
particular
attent
establish
optim
oral
hygien
erad
sourc
potenti
infect
dental
treatment
complet
surgeri
month
surgeri
elect
dental
care
best
defer
surgic
treat
ment
need
period
antibiot
prophylaxi
probabl
warrant
cardiopulmonari
transplant
heart
lung
transplant
simultan
surgic
replac
heart
lung
patient
endstag
cardiac
pulmonari
diseas
organ
cadaver
donor
transplant
recipi
requir
lifelong
immunosuppress
pre
vent
tcell
alloimmun
reject
respons
see
also
chapter
meticul
presurgeri
oral
assess
requir
dental
treatment
must
undertaken
particular
attent
establish
optim
oral
hygien
erad
sourc
potenti
infect
dental
treatment
complet
surgeri
month
surgeri
elect
dental
care
best
defer
surgic
treat
ment
need
period
antibiot
prophylaxi
probabl
warrant
